survey among doctors: pharmacological treatment of patients with epilepsy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035298

Enrollment

5000

Registered

2025-04-14

Start date

2025-09-01

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G40

Interventions

Group 1: Neurologists in practice in Germany with statutory health insurance approval This study will use an anonymous questionnaire sent to neurologists in private practice to investigate the realit

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - completed specialist training in neurology - practice with statutory health insurance approval

Exclusion criteria

Exclusion criteria: completed specialist training in psychiatry

Design outcomes

Primary

Measure	Time frame
How would outpatient neurologists treat patients based on case vigniettes?	—

Secondary

Measure	Time frame
When and under what conditions would outpatient neurologists discontinue anti seizure medication?	—

Countries

Germany

Contacts

Public ContactMartin Holtkamp

Charité - Universitätsmedizin Berlin

martin.holtkamp@charite.de+4930450560822

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026